DT
VBIV

Diversified Trust’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Diversified Trust’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-621
Closed -$13K – 867
2022
Q3 		$13K Buy
+621
New +$16.7K ﹤0.01% 760

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Diversified Trust's VBIV Position: Q4 2022 in Review

Diversified Trust sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2022, closing a stake of 621 shares — an estimated $13K sold.

Diversified Trust first reported a position in VBIV in Q3 2022 and held it in 1 quarter. The position peaked at $13K in Q3 2022. 111 funds tracked by Wall St. Rank hold VBIV as of Q4 2022.

  • Diversified Trust reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2022 after selling out during the quarter.
  • Diversified Trust sold 621 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2022, an estimated $13K.
  • Diversified Trust first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2022 and held it in 1 quarter.
  • Diversified Trust's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $13K in Q3 2022.
  • 111 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2022.

Based on Diversified Trust's 13F filing for Q4 2022, filed 17 Jan 2023.